FARP CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. FARP Gen Silencer sind erhältlich als FARP CRISPR/Cas9 Knockout Plasmide und FARP Double Nickase Plasmide. FARP CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
FARP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FARP1 CRISPR/Cas9 KO Plasmid (h) | sc-402352 | h | Gene Knockout | GFP | 0 | ||
FARP1 HDR Plasmid (h) | sc-402352-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FARP1 Double Nickase Plasmid (h) | sc-402352-NIC | h | Gene Knockout | Puromycin | 0 | ||
FARP1 Double Nickase Plasmid (h2) | sc-402352-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FARP1 CRISPR/Cas9 KO Plasmid (m) | sc-432359 | m | Gene Knockout | GFP | 0 | ||
FARP1 HDR Plasmid (m) | sc-432359-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FARP1 Double Nickase Plasmid (m) | sc-432359-NIC | m | Gene Knockout | Puromycin | 0 | ||
FARP1 Double Nickase Plasmid (m2) | sc-432359-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
FARP2 CRISPR/Cas9 KO Plasmid (h) | sc-411366 | h | Gene Knockout | GFP | 0 | ||
FARP2 HDR Plasmid (h) | sc-411366-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
FARP2 Double Nickase Plasmid (h) | sc-411366-NIC | h | Gene Knockout | Puromycin | 0 | ||
FARP2 Double Nickase Plasmid (h2) | sc-411366-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
FARP2 CRISPR/Cas9 KO Plasmid (m) | sc-432696 | m | Gene Knockout | GFP | 0 | ||
FARP2 HDR Plasmid (m) | sc-432696-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
FARP2 Double Nickase Plasmid (m) | sc-432696-NIC | m | Gene Knockout | Puromycin | 0 | ||
FARP2 Double Nickase Plasmid (m2) | sc-432696-NIC-2 | m | Gene Knockout | Puromycin | 0 |
FARP CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
FARP1 CRISPR Activation Plasmid (h) | sc-402352-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activation Plasmid (h2) | sc-402352-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (h) | sc-402352-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (h2) | sc-402352-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activation Plasmid (m) | sc-432359-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 CRISPR Activation Plasmid (m2) | sc-432359-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (m) | sc-432359-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP1 Lentiviral Activation Particles (m2) | sc-432359-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activation Plasmid (h) | sc-411366-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activation Plasmid (h2) | sc-411366-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (h) | sc-411366-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (h2) | sc-411366-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activation Plasmid (m) | sc-432696-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 CRISPR Activation Plasmid (m2) | sc-432696-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (m) | sc-432696-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
FARP2 Lentiviral Activation Particles (m2) | sc-432696-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |